Literature DB >> 15856024

Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes.

Eva Ceballos1, Maria J Muñoz-Alonso, Bernd Berwanger, Juan C Acosta, Rafael Hernández, Michael Krause, Oliver Hartmann, Martin Eilers, Javier León.   

Abstract

We have previously demonstrated that c-Myc impairs p53-mediated apoptosis in K562 human leukemia cells, which lack ARF. To investigate the mechanisms by which c-Myc protects from p53-mediated apoptosis, we used K562 cells that conditionally express c-Myc and harbor a temperature-sensitive allele of p53. Gene expression profiles of cells expressing wild-type conformation p53 in the presence of either uninduced or induced c-Myc were analysed by cDNA microarrays. The results show that multiple p53 target genes are downregulated when c-Myc is present, including p21WAF1, MDM2, PERP, NOXA, GADD45, DDB2, PIR121 and p53R2. Also, a number of genes that are upregulated by c-Myc in cells expressing wild-type conformation p53 encode chaperones related to cell death protection as HSP105, HSP90 and HSP27. Both downregulation of p53 target genes and upregulation of chaperones could explain the inhibition of apoptosis observed in K562 cells with ectopic c-Myc. Myc-mediated impairment of p53 transactivation was not restricted to K562 cells, but it was reproduced in a panel of human cancer cell lines derived from different tissues. Our data suggest that elevated levels of Myc counteract p53 activity in human tumor cells that lack ARF. This mechanism could contribute to explain the c-Myc deregulation frequently found in cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15856024     DOI: 10.1038/sj.onc.1208652

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.

Authors:  Coralie Dorard; Aurélie de Thonel; Ada Collura; Laetitia Marisa; Magali Svrcek; Anaïs Lagrange; Gaetan Jego; Kristell Wanherdrick; Anne Laure Joly; Olivier Buhard; Jessica Gobbo; Virginie Penard-Lacronique; Habib Zouali; Emmanuel Tubacher; Sylvain Kirzin; Janick Selves; Gérard Milano; Marie-Christine Etienne-Grimaldi; Leila Bengrine-Lefèvre; Christophe Louvet; Christophe Tournigand; Jérémie H Lefèvre; Yann Parc; Emmanuel Tiret; Jean-François Fléjou; Marie-Pierre Gaub; Carmen Garrido; Alex Duval
Journal:  Nat Med       Date:  2011-09-25       Impact factor: 53.440

2.  Microarray study of mechanism of trichostatin a inducing apoptosis of Molt-4 cells.

Authors:  Zhenya Hong; Zhiqiang Han; Min Xiao; Yang Yang; Xi Xia; Jianfeng Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

3.  c-Myc influences olaquindox-induced apoptosis in human hepatoma G2 cells.

Authors:  Ting Zhang; Shu-Sheng Tang; Xi Jin; Feng-Ying Liu; Chao-Ming Zhang; Wen-Xia Zhao; Shen Zhang; Chun-Di Sun; Xi-Long Xiao
Journal:  Mol Cell Biochem       Date:  2011-05-20       Impact factor: 3.396

4.  Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression.

Authors:  El Bachir Affar; Frédérique Gay; Yujiang Shi; Huifei Liu; Maite Huarte; Su Wu; Tucker Collins; En Li; Yang Shi
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

5.  Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.

Authors:  Etienne Moussay; Valérie Palissot; Laurent Vallar; Hélène A Poirel; Thomas Wenner; Victoria El Khoury; Nasséra Aouali; Kris Van Moer; Bernadette Leners; François Bernardin; Arnaud Muller; Pascale Cornillet-Lefebvre; Alain Delmer; Caroline Duhem; Fernand Ries; Eric van Dyck; Guy Berchem
Journal:  Mol Cancer       Date:  2010-05-20       Impact factor: 27.401

6.  RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player.

Authors:  K Häbig; M Walter; S Poths; O Riess; M Bonin
Journal:  Neurogenetics       Date:  2007-12-21       Impact factor: 2.660

7.  Altered adenosine-to-inosine RNA editing in human cancer.

Authors:  Nurit Paz; Erez Y Levanon; Ninette Amariglio; Amy B Heimberger; Zvi Ram; Shlomi Constantini; Zohar S Barbash; Konstantin Adamsky; Michal Safran; Avi Hirschberg; Meir Krupsky; Issachar Ben-Dov; Simona Cazacu; Tom Mikkelsen; Chaya Brodie; Eli Eisenberg; Gideon Rechavi
Journal:  Genome Res       Date:  2007-10-01       Impact factor: 9.043

8.  Diminished origin-licensing capacity specifically sensitizes tumor cells to replication stress.

Authors:  Kristin M Zimmerman; Rebecca M Jones; Eva Petermann; Penelope A Jeggo
Journal:  Mol Cancer Res       Date:  2013-01-30       Impact factor: 5.852

Review 9.  MYC and the art of microRNA maintenance.

Authors:  James N Psathas; Andrei Thomas-Tikhonenko
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-15       Impact factor: 6.915

10.  Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.

Authors:  Dimitra Tsavachidou; Timothy J McDonnell; Sijin Wen; Xuemei Wang; Funda Vakar-Lopez; Louis L Pisters; Curtis A Pettaway; Christopher G Wood; Kim-Anh Do; Peter F Thall; Clifton Stephens; Eleni Efstathiou; Robert Taylor; David G Menter; Patricia Troncoso; Scott M Lippman; Christopher J Logothetis; Jeri Kim
Journal:  J Natl Cancer Inst       Date:  2009-02-24       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.